Thrivent Financial for Lutherans’s VanEck Pharmaceutical ETF PPH Stock Holding History

Thrivent Financial for Lutherans’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.36M	Buy	21,546 +904	+4%	+$93.6K	﹤0.01%	1426
2026 Q1	$2.14M	Buy	20,642 +5,548	+37%	+$591K	﹤0.01%	1387
2025 Q4	$1.56M	Buy	+15,094	New	+$1.47M	﹤0.01%	1636
2025 Q3	–	Sell	-20,681	Closed	-$1.82M	–	2556
2025 Q2	$1.82M	Buy	+20,681	New	+$1.79M	﹤0.01%	1416
2025 Q1	–	Sell	-153,063	Closed	-$13.2M	–	2503
2024 Q4	$13.2M	Sell	153,063 -81,827	-35%	-$7.4M	0.03%	575
2024 Q3	$22.3M	Buy	234,890 +59,025	+34%	+$5.61M	0.04%	437
2024 Q2	$16.1M	Buy	+175,865	New	+$15.7M	0.03%	515

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Thrivent Financial for Lutherans's PPH Position: Q2 2026 in Review

Thrivent Financial for Lutherans increased its VanEck Pharmaceutical ETF (PPH) stake by 4.4% in Q2 2026, buying an estimated $93.6K and bringing the position to 21,546 shares worth $2.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1426.

Thrivent Financial for Lutherans first reported a position in PPH in Q2 2024 and has held it in 7 quarters since. The position peaked at $22.3M in Q3 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Thrivent Financial for Lutherans held 21,546 shares of VanEck Pharmaceutical ETF worth $2.36M as of Q2 2026.
Thrivent Financial for Lutherans bought 904 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $93.6K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q2 2026, its #1426 holding.
Thrivent Financial for Lutherans first reported a position in VanEck Pharmaceutical ETF in Q2 2024 and has held it in 7 quarters since.
Thrivent Financial for Lutherans's VanEck Pharmaceutical ETF position peaked at $22.3M in Q3 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.